117 related articles for article (PubMed ID: 8224652)
21. Prostaglandin E1 maintains structural integrity of intestinal mucosa and prevents bacterial translocation during experimental obstructive jaundice.
Gurleyik E; Coskun O; Ustundag N; Ozturk E
J Invest Surg; 2006; 19(5):283-9. PubMed ID: 16966206
[TBL] [Abstract][Full Text] [Related]
22. Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.
Shibamoto T; Kamikado C; Koyama S
Pflugers Arch; 2008 Jun; 456(3):467-77. PubMed ID: 18193271
[TBL] [Abstract][Full Text] [Related]
23. Reduced gastric surface mucus layer in experimental portal hypertension.
Imanishi H; Harihara Y; Bandai Y; Sanjo K; Makuuchi M
J Gastroenterol; 1997 Dec; 32(6):720-5. PubMed ID: 9430008
[TBL] [Abstract][Full Text] [Related]
24. Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats.
Lee SS; Sharkey KA
Am J Physiol; 1993 May; 264(5 Pt 1):G868-73. PubMed ID: 8498513
[TBL] [Abstract][Full Text] [Related]
25. Experimental study of the effect of intraportal prostaglandin E1 on hepatic blood flow during reperfusion after ischaemia and hepatectomy.
Hossain MA; Hamamoto I; Wakabayashi H; Goda F; Kobayashi S; Maeba T; Maeta H
Br J Surg; 1999 Jun; 86(6):776-83. PubMed ID: 10383578
[TBL] [Abstract][Full Text] [Related]
26. Portal vein clamping alone confers protection against hepatic ischemia-reperfusion injury via preserving hepatocyte function in cirrhotic rats.
Hu JJ; Li CH; Wang HD; Xu WL; Zhang AQ; Dong JH
J Surg Res; 2015 Mar; 194(1):139-46. PubMed ID: 25481529
[TBL] [Abstract][Full Text] [Related]
27. Altered hepatic hemodynamics and improved liver function following intrahepatic vascular infusion of prostaglandin E1.
Nakai T; Tanimura H; Hirokawa F; Tamaki T
J Gastroenterol; 1998 Jun; 33(3):362-7. PubMed ID: 9658315
[TBL] [Abstract][Full Text] [Related]
28. Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
Cerini F; Vilaseca M; Lafoz E; García-Irigoyen O; García-Calderó H; Tripathi DM; Avila M; Reverter JC; Bosch J; Gracia-Sancho J; García-Pagán JC
J Hepatol; 2016 Apr; 64(4):834-42. PubMed ID: 26686269
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
30. Effects of ammonia solution on the gastric mucosa in cirrhotic rats and therapeutic effects of geranylgeranylacetone.
Sugimoto M; Machida Y; Ito K
J Gastroenterol Hepatol; 1999 Jun; 14(6):529-33. PubMed ID: 10385060
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin-E1 has a protective effect on renal ischemia/reperfusion-induced oxidative stress and inflammation mediated gastric damage in rats.
Gezginci-Oktayoglu S; Orhan N; Bolkent S
Int Immunopharmacol; 2016 Jul; 36():142-150. PubMed ID: 27135545
[TBL] [Abstract][Full Text] [Related]
32. Effects of prostaglandin E1 on the recovery of ischemia-induced liver mitochondrial dysfunction in rats with cirrhosis.
Kurokawa T; Nonami T; Harada A; Nakao A; Sugiyama S; Ozawa T; Takagi H
Scand J Gastroenterol; 1991 Mar; 26(3):269-74. PubMed ID: 1853149
[TBL] [Abstract][Full Text] [Related]
33. PGE2 alleviates kidney and liver damage, decreases plasma renin activity and acute phase response in cirrhotic rats with acute liver damage.
Rincón-Sánchez AR; Covarrubias A; Rivas-Estilla AM; Pedraza-Chaverrí J; Cruz C; Islas-Carbajal MC; Panduro A; Estanes A; Armendáriz-Borunda J
Exp Toxicol Pathol; 2005 Mar; 56(4-5):291-303. PubMed ID: 15816358
[TBL] [Abstract][Full Text] [Related]
34. Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.
D'Amico M; Mejías M; García-Pras E; Abraldes JG; García-Pagán JC; Fernández M; Bosch J
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1191-8. PubMed ID: 22403792
[TBL] [Abstract][Full Text] [Related]
35. Effect of prostaglandin E1 on ammonia concentration in blood of patients with hepatic resection.
Aono T; Sakaguchi T; Tsukada K; Kurosaki I; Hatakeyama K
Dig Dis Sci; 1996 Jan; 41(1):126-30. PubMed ID: 8565744
[TBL] [Abstract][Full Text] [Related]
36. Taurocholate induced gastric mucosal injuries in experimental portal hypertension.
Angerson WJ; Geraghty JG; Carter DC
Gut; 1992 Feb; 33(2):170-4. PubMed ID: 1541411
[TBL] [Abstract][Full Text] [Related]
37. Experimental colitis in rats with portal hypertension and liver disease.
Ackerman Z; Karmeli F; Cohen P; Rachmilewitz D
Inflamm Bowel Dis; 2003 Jan; 9(1):18-24. PubMed ID: 12656133
[TBL] [Abstract][Full Text] [Related]
38. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
[TBL] [Abstract][Full Text] [Related]
39. Impaired vasodilatory responses in the gastric microcirculation of anesthetized rats with secondary biliary cirrhosis.
Ferraz JG; McKnight W; Sharkey KA; Wallace JL
Gastroenterology; 1995 Apr; 108(4):1183-91. PubMed ID: 7698587
[TBL] [Abstract][Full Text] [Related]
40. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
